• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $GL

    Globe Life Inc.

    Subscribe to $GL
    $GL
    Life Insurance
    Finance

    Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.

    IPO Year:

    Exchange: NYSE

    Website: globelifeinsurance.com

    Recent Analyst Ratings for Globe Life Inc.

    DatePrice TargetRatingAnalyst
    1/23/2025$114.00Market Perform
    BMO Capital Markets
    1/8/2025$132.00 → $143.00In-line → Outperform
    Evercore ISI
    10/9/2024$150.00Buy
    TD Cowen
    4/24/2024$130.00 → $110.00Mkt Perform → Outperform
    Keefe Bruyette
    10/31/2023$122.00 → $137.00Equal Weight → Overweight
    Wells Fargo
    8/18/2023$131.00Underweight → Equal-Weight
    Morgan Stanley
    4/25/2023$120.00Equal Weight
    Wells Fargo
    10/28/2022$115.00 → $114.00Outperform → In-line
    Evercore ISI
    9/22/2022$138.00Strong Buy
    Raymond James
    6/15/2022$105.00 → $112.00In-line → Outperform
    Evercore ISI
    See more ratings